As of 6 Nov 2026, Family Care Hospitals is loss-making on a trailing 12-month basis, with a net loss of ₹8.41 Cr, so it has no P/E ratio. The share price is ₹1.97, 52% below its 52-week high. Sales fell 83% a year over 3 years. Debt is 0.55× equity. It is a small-cap company with a market cap of ₹11 Cr, ranked 38th of 40 Medical Care Facilities companies by market cap; the shares fell 53% over the past year.
- ₹1.99
- ₹1.99
- ₹1.92
- ₹1.92
- 60.3K
Health check
- ReturnsBehind
−53.2% over a year, better than 0 of 7 peers.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- GrowthShrinking
Sales −82.9% a year over 3 years.
- ProfitabilityNegative
ROCE -85.5% vs peer median 11.9%.
- Balance sheetStretched
Debt 0.55× equity, operating profit doesn’t cover interest, Piotroski 3 of 9.
- Red flags4 to check
Loss-making over the last twelve months.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹11 Cr
- Small cap
- P/E
- n/a
- Industry 47.7
- Price to book
- 1.12
- Peers 8.06
- Dividend yield
- 0.00%
- ROE
- −75.8%
- Peers 12.8%
- ROCE
- −85.5%
- Peers 11.9%
- Debt to equity
- 0.55
- Debt ₹5.17 Cr
- EPS (TTM)
- −₹1.56
- OPM (TTM)
- −2798.7%
- Net margin 0.0%
- Sales growth
- +190.7%
- Latest quarter vs a year ago
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- 43.86
- EV/EBITDA −4.8
Strengths and risks
Strengths
- Quarterly sales up 190.7% on a year ago.
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at −75.8%.
- 52% below its 52-week high.
- Interest coverage of only −5.4×.
About Family Care Hospitals
Family Care Hospitals Limited engages in the healthcare services business in India. The company offers general surgeries, gynecology, orthopedics, ENT, cardiology, urology, oncology, plastic surgery, and proctology services. It is also involved in the operation of an online pharmacy application, as well as offers solutions for various therapeutics areas, including cardiology, dermatology, diabetology, gastroenterology, general-laparoscopy-surgery,…
- Headquarters
- Thane
- Employees
- 8
- Sector
- Healthcare
- ISIN
- INE146N01016
- Website
- familycarehospitals.com
Price range
- Avg volume (3M)
- 1.7 L
- 1-year return
- minus 53.2%
- From 52-week high
- minus 52.0%
Peers · Medical Care Facilities
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSPApollo Hospitals Enterprise | 8,446.00 | plus 0.90% | 1,21,441 | 54.0 | 11.45 | 19.2% | 22.5% | 15.4% | 14.8% | 33.3% | 0.24% | plus 7.2% |
| MAXHEALTHMax Healthcare Institute | 934.00 | plus 0.21% | 90,909 | 66.1 | 8.03 | 12.6% | 12.8% | 26.8% | 22.4% | 9.3% | 0.21% | minus 18.1% |
| MANIPALHOSManipal Health Enterprises | 646.70 | minus 1.61% | 85,065 | 133.6 | 9.05 | 9.8% | 9.2% | 17.8% | – | – | 0.00% | minus 3.0% |
| ASTERDMAster DM Quality Care | 713.15 | minus 0.89% | 62,092 | 90.7 | 8.06 | 9.4% | 9.7% | 17.4% | 15.7% | −3.0% | 0.42% | plus 4.5% |
| FORTISFortis Healthcare | 766.90 | minus 6.45% | 57,898 | 55.7 | 5.52 | 11.9% | 10.4% | 22.2% | 13.3% | 20.9% | 0.13% | minus 19.6% |
| NHNarayana Hrudayalaya | 1,903.00 | minus 0.65% | 38,650 | 44.7 | 7.73 | 11.4% | 19.1% | 18.5% | 20.5% | 9.9% | 0.24% | plus 4.7% |
| MEDANTAGlobal Health | 1,387.60 | minus 0.15% | 37,264 | 60.4 | 8.63 | 15.0% | 15.2% | 22.1% | 17.2% | 19.5% | 0.04% | plus 11.2% |
| FAMILYCAREFamily Care Hospitals | 1.97 | plus 2.60% | 11 | – | 1.12 | −85.5% | −75.8% | −2798.7% | −82.9% | – | 0.00% | minus 53.2% |
| Median of 7 peers | – | −0.65% | 62,092 | 60.4 | 8.06 | 11.9% | 12.8% | 18.5% | 16.5% | 14.7% | 0.21% | 4.5% |
Quarterly results
| ₹ Cr | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Jun 26 |
|---|---|---|---|---|---|
| 0 | 0 | 0.1 | 0.1 | 0.1 | |
| 0.8 | 0.4 | 4.5 | 0.7 | 0.2 | |
| −0.8 | −0.4 | −4.4 | −0.7 | −0.2 | |
| −3111.1% | −2259.9% | −5945.0% | −1132.8% | −342.4% | |
| 2 | 0 | 0.1 | 0 | 0 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
| −0.2 | – | – | – | – | |
| 0.7 | −0.7 | −4.6 | −1 | −0.4 | |
| −48.0% | – | – | – | – | |
| 1 | −0.7 | −4.6 | −1 | −0.4 | |
| – | -0.39 | -0.85 | -0.18 | -0.08 |
Profit & loss
- Sales CAGR 3Y
- −82.9%
- ROE
- −75.8%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 42 | 40 | 7.9 | 0.2 | |
| – | minus 4.8% | minus 80.2% | minus 97.3% | |
| 33.6 | 33.2 | −20.8 | 2.2 | |
| 8.4 | 6.8 | 28.7 | −2 | |
| 20.0% | 17.0% | 363.1% | −964.5% | |
| 0.9 | 3.2 | 3.1 | 0.2 | |
| 0.5 | 0.4 | 0.3 | 0.4 | |
| 1.4 | 1.4 | 1.1 | 0.9 | |
| −0 | −0 | −74.9 | −5.6 | |
| 7.4 | 8.1 | −44.5 | −8.7 | |
| 29.1% | −54.3% | 0.7% | – | |
| 5.3 | 12.5 | −44.1 | −8.7 | |
| – | +138.7% | minus 451.8% | – | |
| 1.56 | 2.32 | -8.17 | -1.61 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 54 | 54 | 54 | 54 | |
| −8.2 | 4.4 | −40.6 | −44.6 | |
| 4.3 | 3.7 | 3.4 | 5.2 | |
| 24.5 | 7.9 | 29.2 | 28.5 | |
| 74.6 | 70 | 46.1 | 43.1 | |
| 7 | 6 | 4 | 2.9 | |
| 0.3 | 0.3 | 0.2 | – | |
| 8.7 | 8.2 | 0.7 | – | |
| 19.3 | 17.5 | 0.2 | 0.3 | |
| 39.2 | 38 | 40.9 | 39.9 | |
| 74.6 | 70 | 46.1 | 43.1 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −5.3 | −0.4 | −17.3 | −6 | |
| −1.5 | −0.4 | 0.7 | – | |
| 25.9 | −1 | −0.6 | 6.1 | |
| 19.1 | −1.8 | −17.2 | 0 | |
| −2 | −0.4 | −0.3 | – | |
| −7.3 | −0.8 | −17.6 | −6 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.